Drugs / Phosphoethanolamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02950103 | Aug 2016 → Mar 2017 | neoplasm | Secretaria de Estado da Saúde | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phosphoethanolamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02950103 ↗ |
| Modality | Small molecule | “Synthetic phosphoethanolamine is a primary amine” NCT02950103 ↗ |
| Route | Oral | “Phosphoethanolamine PO daily” NCT02950103 ↗ |